Homo sapiens IRCHF1A breast and ovarian cancer susceptibility protein - Nucleotide

Run BLAST
Find regions of similarity between this sequence and other sequences using BLAST.
Pick Primers
Design and test primers for this sequence using Primer-BLAST.

Hereditary breast cancer next-generation sequencing panel evaluation in the south region of Brazil: A novel BRCA2 candidate pathogenic variant is reported. [Mol Genet Genomic Med. 2024]
Hereditary breast cancer next-generation sequencing panel evaluation in the south region of Brazil: A novel BRCA2 candidate pathogenic variant is reported.
Duarte CAB, Dos Santos CA, de Oliveira CDD, Spautz CC, Sumita LM, Nakatani SM. Mol Genet Genomic Med. 2024 Aug; 12(8):e2504.
[Prostate cancer with BRCA2 pathogenic mutation: a clinicopathological analysis]. [Zhonghua Bing Li Xue Za Zhi. 2...]
[Prostate cancer with BRCA2 pathogenic mutation: a clinicopathological analysis].
Wang DH, Yin WL, Pan XY, Zhang MN, Nie L, Chen XQ, Zeng H, Zhou Q, Chen N. Zhonghua Bing Li Xue Za Zhi. 2024 Aug 8; 53(8):789-796.
Germline biallelic BRCA2 pathogenic variants and medulloblastoma: an international cohort study. [J Hematol Oncol. 2024]
Germline biallelic BRCA2 pathogenic variants and medulloblastoma: an international cohort study.
Kastellan S, Kalb R, Sajjad B, McReynolds LJ, Giri N, Samuel D, Milde T, Elbracht M, Holzhauer S, Niewisch MR, et al. J Hematol Oncol. 2024 Apr 29; 17(1):26. Epub 2024 Apr 29.

RefSeq alternative splicing
See 6 reference mRNA sequence splice variants for the BRCA2 gene.

Your browsing activity is empty.

Activity recording is turned off.

Nucleotide